Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000006

Director sold 49,546 shares at an average $29.99 ($1,485,790)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Booth Bruce · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-03 Sale : show line 1 in the form 10b5-1 −31,198 $30.00 $935,940 2,790,054 I
2025-10-03 Sale : show line 2 in the form 10b5-1 −6,548 $30.00 $196,440 787,527 I
2025-10-06 Sale : show line 3 in the form 10b5-1 −9,753 $29.95 $292,102 2,780,301 I
2025-10-06 Sale : show line 4 in the form 10b5-1 −2,047 $29.95 $61,308 785,480 I
Open-market sales · 49,546 sh · avg $29.99 · $1,485,790
Loading xslF345X05/form4-10072025_091026.xml…